甲磺酸伊马替尼及其活性代谢产物血浆谷浓度对胃肠间质瘤患者中重度不良反应发生风险的预测价值

张梦华,陈之遥,刘筱雪,单治理,杨刚,周启阳,周雨迪,周晓俊,缪丽燕

PDF(554 KB)
PDF(554 KB)
药物不良反应杂志 ›› 2021, Vol. 23 ›› Issue (10) : 517-522. DOI: 10.3760/cma.j.cn114015-20210413-00446
论著

甲磺酸伊马替尼及其活性代谢产物血浆谷浓度对胃肠间质瘤患者中重度不良反应发生风险的预测价值

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Value of trough plasma concentration of imatinib mesylate and its active metabolite in predicting the risk of moderate to severe adverse reactions in patients with gastrointestinal stromal tumors

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

本文二维码

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2021, 23(10): 517-522 https://doi.org/10.3760/cma.j.cn114015-20210413-00446
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 23(10): 517-522 https://doi.org/10.3760/cma.j.cn114015-20210413-00446

参考文献

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(554 KB)

Accesses

Citation

Detail

段落导航
相关文章

/